CHELSEA BRIAN: Open Payments
NPI 1285389353 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 7 payments from 4 companies in 2025. Trend: 2023 $98 · 2024 $355 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $82 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Novo Nordisk Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Veozah, INJECTAFER, Wegovy, MOUNJARO.
Industry payments across ID — which companies pay providers there.
